WGS(GeneDx Holdings Corp.) 的内部人交易:医疗保健,诊断与研究。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-16 | Feeley Kevin | CHIEF FINANCIAL OFFICER | 公开市场卖出 | 1,079 | $99.00 |
| 2026-09-16 | Feeley Kevin | CHIEF FINANCIAL OFFICER | 公开市场卖出 | 1,470 | $98.27 |
| 2026-09-16 | Feeley Kevin | CHIEF FINANCIAL OFFICER | 公开市场卖出 | 541 | $96.90 |
| 2026-09-16 | Feeley Kevin | CHIEF FINANCIAL OFFICER | 公开市场卖出 | 52 | $95.41 |
| 2026-09-16 | Feeley Kevin | CHIEF FINANCIAL OFFICER | 公开市场卖出 | 586 | $94.26 |
| 2026-09-16 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | 公开市场卖出 | 3,039 | $99.00 |
| 2026-09-16 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | 公开市场卖出 | 4,141 | $98.27 |
| 2026-09-16 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | 公开市场卖出 | 1,525 | $96.90 |
| 2026-09-16 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | 公开市场卖出 | 148 | $95.41 |
| 2026-09-16 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | 公开市场卖出 | 1,648 | $94.26 |
| 2026-09-09 | Feeley Kevin | CHIEF FINANCIAL OFFICER | 公开市场卖出 | 1,285 | $84.22 |
| 2026-09-09 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | 公开市场卖出 | 3,692 | $84.22 |
| 2026-09-01 | Feeley Kevin | CHIEF FINANCIAL OFFICER | 公开市场卖出 | 372 | $83.84 |
| 2026-06-16 | Feeley Kevin | CHIEF FINANCIAL OFFICER | 公开市场卖出 | 863 | $61.50 |
| 2026-06-16 | Feeley Kevin | CHIEF FINANCIAL OFFICER | 公开市场卖出 | 2,106 | $60.83 |
| 2026-06-16 | Feeley Kevin | CHIEF FINANCIAL OFFICER | 公开市场卖出 | 760 | $59.75 |
| 2026-06-16 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | 公开市场卖出 | 2,429 | $61.50 |
| 2026-06-16 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | 公开市场卖出 | 5,932 | $60.83 |
| 2026-06-16 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | 公开市场卖出 | 2,140 | $59.75 |
| 2026-06-09 | Feeley Kevin | CHIEF FINANCIAL OFFICER | 公开市场卖出 | 1,266 | $53.77 |